Hims & Hers Health faces a 99.6% market-implied probability of missing consensus estimates for its Q2 2026 results due to persistent profitability challenges despite revenue expansion. Analysts project EPS around -$0.05 amid higher operating costs and investments in weight-loss offerings, following the Q1 2026 miss where actual EPS of -$0.40 fell well short of the +$0.04 consensus. Revenue growth to an expected $680–713 million range reflects subscriber gains near 2.9 million, yet margin pressure from competitive dynamics and guidance updates has reinforced trader skepticism. The earnings release scheduled for August 10 could still shift odds if results exceed lowered expectations or management signals improved Adjusted EBITDA trajectory.
Tóm tắt AI thử nghiệm tham chiếu dữ liệu Polymarket. Đây không phải tư vấn giao dịch và không ảnh hưởng đến cách thị trường này được giải quyết. · Cập nhậtWill Hims & Hers Health (HIMS) beat quarterly earnings?
Will Hims & Hers Health (HIMS) beat quarterly earnings?
<1% khả năng
$6,522 KL.
$6,522 KL.
Aug 10, 2026
<1% khả năng
$6,522 KL.
$6,522 KL.
Aug 10, 2026
As of market creation, Hims & Hers Health is estimated to release earnings on August 10, 2026. The Street consensus estimate for Hims & Hers Health's GAAP EPS for the relevant quarter is $-0.05 as of market creation. This market will resolve to "Yes" if Hims & Hers Health reports GAAP EPS greater than $-0.05 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the GAAP EPS listed in the company’s official earnings documents.
If Hims & Hers Health releases earnings without GAAP EPS, then the market will resolve according to the GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve to “No”.
If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.”
Note: Subsequent restatements, corrections, or revisions made to the initially announced GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024).
Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for GAAP EPS.
Note: All figures will be rounded to the nearest cent using standard rounding.
Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS.
Note: For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless this is not published, in which case it refers to basic GAAP EPS.
Note: All figures are expressed in USD, unless otherwise indicated.
Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
Hims & Hers Health faces a 99.6% market-implied probability of missing consensus estimates for its Q2 2026 results due to persistent profitability challenges despite revenue expansion. Analysts project EPS around -$0.05 amid higher operating costs and investments in weight-loss offerings, following the Q1 2026 miss where actual EPS of -$0.40 fell well short of the +$0.04 consensus. Revenue growth to an expected $680–713 million range reflects subscriber gains near 2.9 million, yet margin pressure from competitive dynamics and guidance updates has reinforced trader skepticism. The earnings release scheduled for August 10 could still shift odds if results exceed lowered expectations or management signals improved Adjusted EBITDA trajectory.
As of market creation, Hims & Hers Health is estimated to release earnings on August 10, 2026. The Street consensus estimate for Hims & Hers Health's GAAP EPS for the relevant quarter is $-0.05 as of market creation. This market will resolve to "Yes" if Hims & Hers Health reports GAAP EPS greater than $-0.05 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the GAAP EPS listed in the company’s official earnings documents.
If Hims & Hers Health releases earnings without GAAP EPS, then the market will resolve according to the GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve to “No”.
If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.”
Note: Subsequent restatements, corrections, or revisions made to the initially announced GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024).
Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for GAAP EPS.
Note: All figures will be rounded to the nearest cent using standard rounding.
Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS.
Note: For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless this is not published, in which case it refers to basic GAAP EPS.
Note: All figures are expressed in USD, unless otherwise indicated.
Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
If Hims & Hers Health releases earnings without GAAP EPS, then the market will resolve according to the GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve to “No”.
If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.”
Note: Subsequent restatements, corrections, or revisions made to the initially announced GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024).
Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for GAAP EPS.
Note: All figures will be rounded to the nearest cent using standard rounding.
Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS.
Note: For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless this is not published, in which case it refers to basic GAAP EPS.
Note: All figures are expressed in USD, unless otherwise indicated.
Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
Thị trường mở: Jul 27, 2026, 10:09 PM ET
Khối lượng
$6,522Ngày kết thúc
Aug 10, 2026Thị trường mở
Jul 27, 2026, 10:09 PM ETNguồn giải quyết
https://seekingalpha.com/Người giải quyết
0x65070BE91...Kết quả đề xuất: No
Không tranh chấp
Kết quả cuối cùng: No
As of market creation, Hims & Hers Health is estimated to release earnings on August 10, 2026. The Street consensus estimate for Hims & Hers Health's GAAP EPS for the relevant quarter is $-0.05 as of market creation. This market will resolve to "Yes" if Hims & Hers Health reports GAAP EPS greater than $-0.05 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the GAAP EPS listed in the company’s official earnings documents.
If Hims & Hers Health releases earnings without GAAP EPS, then the market will resolve according to the GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve to “No”.
If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.”
Note: Subsequent restatements, corrections, or revisions made to the initially announced GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024).
Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for GAAP EPS.
Note: All figures will be rounded to the nearest cent using standard rounding.
Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS.
Note: For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless this is not published, in which case it refers to basic GAAP EPS.
Note: All figures are expressed in USD, unless otherwise indicated.
Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
Hims & Hers Health faces a 99.6% market-implied probability of missing consensus estimates for its Q2 2026 results due to persistent profitability challenges despite revenue expansion. Analysts project EPS around -$0.05 amid higher operating costs and investments in weight-loss offerings, following the Q1 2026 miss where actual EPS of -$0.40 fell well short of the +$0.04 consensus. Revenue growth to an expected $680–713 million range reflects subscriber gains near 2.9 million, yet margin pressure from competitive dynamics and guidance updates has reinforced trader skepticism. The earnings release scheduled for August 10 could still shift odds if results exceed lowered expectations or management signals improved Adjusted EBITDA trajectory.
As of market creation, Hims & Hers Health is estimated to release earnings on August 10, 2026. The Street consensus estimate for Hims & Hers Health's GAAP EPS for the relevant quarter is $-0.05 as of market creation. This market will resolve to "Yes" if Hims & Hers Health reports GAAP EPS greater than $-0.05 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the GAAP EPS listed in the company’s official earnings documents.
If Hims & Hers Health releases earnings without GAAP EPS, then the market will resolve according to the GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve to “No”.
If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.”
Note: Subsequent restatements, corrections, or revisions made to the initially announced GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024).
Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for GAAP EPS.
Note: All figures will be rounded to the nearest cent using standard rounding.
Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS.
Note: For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless this is not published, in which case it refers to basic GAAP EPS.
Note: All figures are expressed in USD, unless otherwise indicated.
Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
If Hims & Hers Health releases earnings without GAAP EPS, then the market will resolve according to the GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve to “No”.
If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.”
Note: Subsequent restatements, corrections, or revisions made to the initially announced GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024).
Note: The strike prices used in these markets are derived from SeekingAlpha estimates, and reflect the consensus of sell-side analyst estimates for GAAP EPS.
Note: All figures will be rounded to the nearest cent using standard rounding.
Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS.
Note: For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless this is not published, in which case it refers to basic GAAP EPS.
Note: All figures are expressed in USD, unless otherwise indicated.
Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
Khối lượng
$6,522Ngày kết thúc
Aug 10, 2026Thị trường mở
Jul 27, 2026, 10:09 PM ETNguồn giải quyết
https://seekingalpha.com/Người giải quyết
0x65070BE91...Kết quả đề xuất: No
Không tranh chấp
Kết quả cuối cùng: No
Hims & Hers Health faces a 99.6% market-implied probability of missing consensus estimates for its Q2 2026 results due to persistent profitability challenges despite revenue expansion. Analysts project EPS around -$0.05 amid higher operating costs and investments in weight-loss offerings, following the Q1 2026 miss where actual EPS of -$0.40 fell well short of the +$0.04 consensus. Revenue growth to an expected $680–713 million range reflects subscriber gains near 2.9 million, yet margin pressure from competitive dynamics and guidance updates has reinforced trader skepticism. The earnings release scheduled for August 10 could still shift odds if results exceed lowered expectations or management signals improved Adjusted EBITDA trajectory.
Tóm tắt AI thử nghiệm tham chiếu dữ liệu Polymarket. Đây không phải tư vấn giao dịch và không ảnh hưởng đến cách thị trường này được giải quyết. · Cập nhật
Cẩn thận với liên kết bên ngoài.
Cẩn thận với liên kết bên ngoài.
Câu hỏi thường gặp